Introduction {#sec1-1}
============

Small leucine-rich proteoglycans (SLRPs) have been identified as important components in the extracellular matrix (ECM) and are involved in several biological and pathological processes in various tissues. They are proteoglycans (PGs) with small core proteins of tandem leucine-rich repeats that carry one or more glycosamino - glycan (GAG) chains, such as chondroitin sulfate (CS), dermatan sulfate (DS), or keratan sulfate (KS). Eighteen SLRP genes have been identified to date and are classified into five categories based on their characteristics at both the genomic and protein levels.^[@ref1]^ It has been reported that these SLRPs play significant roles in regulating the ECM by collagen formation and ECM arrangement, matrix mineralization, signal transduction, and epithelialmesenchymal interactions, as well as in immunity and tumor growth.^[@ref4]^

The most commonly identified SLRPs in teeth are of class I and class II.^[@ref5]^ Class I SLRPs include decorin and biglycan, which are the most studied and are relatively abundant. They are found in various tissues, such as skin, tendon, bone, cartilage, and muscle.^[@ref6]^ They contain CS/DS chains; one in decorin and two in biglycan. Decorin plays a significant role in collagen fibrillogenesis and in preventing premature mineralization,^[@ref7]^ whereas biglycan is more significant in osteoblast differentiation and matrix mineralization.^[@ref8]^ In geneknockout studies, the absence of *decorin* gives rise to skin fragility and dysregulation of lateral fibril growth.^[@ref9]^ Likewise, the absence of *biglycan* results in osteoporosis-like phenotypes.^[@ref10]^

Class II SLRPs include fibromodulin and lumican, which are close relatives of decorin and biglycan in terms of their function. They have KS chains and are found in tissues such as tendons, cartilage, sclera, and the cornea.^[@ref6]^ Goldberg *et al.*^[@ref11],[@ref12]^ identified two different molecular weights for fibromodulin present in bone and dentin, the former of which is larger. Lumican is also involved in collagen fibrillogenesis and determines the collagen fiber diameter and spacing.^[@ref13]^ It is also recognized as a marker for the identification of differentiating and mature osteoblasts from undifferentiated osteoblasts.^[@ref14]^

Tooth development is a complex process regulated by epithelialmesenchymal interactions and continues through different developmental stages known as bud, cap, bell, and apposition stages.^[@ref15]^ Throughout the tooth developmental process, the involvement of versican, a large CS- PG;^[@ref16]^ perlecan, a large heparan sulfate (HS)-PG;^[@ref17]^ and syndecans, small cell surface HS-PGs,^[@ref18]^ have been thoroughly investigated. Several studies have also confirmed the involvement of SLRPs in tooth development in humans^[@ref13],[@ref19],[@ref20]^ and other species.^[@ref21]^

SLRPs have been proposed to play several roles in tooth development, including cellular differentiation, collagen fibrillogenesis, dental mineralization, and tooth eruption.^[@ref24]^ To elucidate the exact roles of SLRPs in tooth formation, geneknockout studies have been carried out. The absence of *decorin* has been found to affect dentin mineralization, whereas biglycan has been shown to have a multifunctional involvement, the knockout of which affects both amelogenesis and dentinogenesis, together with collagen fibrillogenesis in predentin.^[@ref25]^ *Fibromodulin* deficiency has been found to affect enamel formation and increases the collagen diameter in predentin, as well as causing dentin hypomineralization in newborn mice, in contrast to the self-repair observed in adult mice.^[@ref11],[@ref12]^ *Lumican* deficiency results in periodontal ligament phenotypes.^[@ref26]^ Many immunohistochemical studies in tooth germs have also been performed in rodents^[@ref21],[@ref27]^ and humans.^[@ref13],[@ref20]^ Several *in situ* hybridization studies in mice have also been carried out.^[@ref28]^ These studies, however, have not examined the temporal changes in *SLRP* expression during the process of identical tooth germ formation. Thus, our hypothesis that SLRPs are closely involved in tooth formation led us to perform an *in situ* hybridization study to elucidate their specific functions by investigating the formation of identical tooth germs (of the lower first molar) from the early stage to the postnatal stage. Simultaneously, the synthesis of SLRP proteins by tooth germs was investigated by immunohistochemistry and an organ culture system using metabolic labeling of \[^35^S\].

Materials and Methods {#sec1-2}
=====================

Animals {#sec2-1}
-------

A total of 16 pregnant Institute of Cancer Research (ICR) mice at embryonic day (E) 13.5 to E18.5 (08:00 h on the day of the vaginal plug was designated as stage E0), and a total of 12 postnatal day (P) 1.0, 3.0, and 7.0 mice were used in this study. All animals were housed in facilities approved by Tokyo Medical and Dental University. Our animal use protocol and experimental system were approved by the Institutional Animal Care and Use Committee of Tokyo Medical and Dental University (2016-009A, A2017-151A, A2018-005A, and A2019-009A).

Tissue preparation {#sec2-2}
------------------

Pregnant and postnatal mice were sacrificed by cervical dislocation under CO~2~ asphyxiation. The heads and lower limbs of the fetal and postnatal mice were separated and were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 at 4°C for 1 day. The E18.5, P1.0, P3.0, and P7.0 specimens were decalcified in 10% ethylenediamine tetraacetic acid (EDTA) at 4°C for 10 days. All specimens were then embedded in paraffin. Frontal or sagittal sections of 5 μm in thickness were obtained for toluidine blue (TB) general staining, immunohistochemistry, and *in situ* hybridization.

*In situ* hybridization {#sec2-3}
-----------------------

All primer sequences used are listed in [Table 1](#table001){ref-type="table"}. The cDNA products were subcloned into a pCR II vector (Stratagene, La Jolla, CA, USA), and antisense and sense RNA probes were synthesized. Each probe was then labeled with \[^35^S\]-UTP using the Riboprobe *in vitro* Transcription System (Promega, Madison, WI, USA). *In situ* hybridization using \[^35^S\]-UTP labeled probes was performed as previously described.^[@ref31]^ Following hybridization and RNase treatment, the sections were dipped in emulsion (NTB; Kodak, Rochester, NY, USA) and exposed for 2 weeks at 4°C for autoradiography. Sense probes were used as negative control samples. We examined three different samples for each embryonic day to ensure that consistent results were obtained.

###### 

Primer sets for RNA probes.

  -----------------------------------------------------------------------------------
  Gene             Primer sequence (5\'-3\')          Product size   
  ---------------- ---------------------------------- -------------- ----------------
  *Decorin*        Forward: GCTCACGCAGTGAAACCTTAG\    754 bp         NM_001190451.2
                   Reverse: CGCCCAGTTCTATGACAAGC                     

  *Biglycan*       Forward: ATTGAGATGGGCGGGAATCC\     721 bp         NM_007542.5
                   Reverse: GGTTGAGGGGAATGGGTGAG                     

  *Fibromodulin*   Forward: AGTCCACCTACTACGACCCC\     878 bp         NM_021355
                   Reverse: ACTCATTGATCCTGTTGCCC                     

  *Lumican*        Forward: AGTAAGGTCACAGAGGACTTGC\   774 bp         NM_008524
                   Reverse: CGAGTTTCCAGGTACCCCAC                     
  -----------------------------------------------------------------------------------

Immunohistochemistry {#sec2-4}
--------------------

Rabbit polyclonal antibodies against decorin, biglycan, and fibromodulin were obtained from Bioss Antibodies (Boston, MA, USA). A rabbit polyclonal antibody against human lumican was obtained from Funakoshi (Tokyo, Japan). Immunohistochemical staining was performed as previously described.^[@ref32],[@ref34],[@ref35]^ Briefly, the sections were deparaffinized and digested with testicular hyaluronidase (25 mg/mL in phosphate buffered saline; Sigma- Aldrich, St. Louis, MO, USA) for 1 h at 37°C. Then, the sections were immersed in methanol containing 1% hydrogen peroxide, followed by 1% bovine serum albumin to block endogenous peroxidase activity and non-specific binding, respectively. The primary antibodies diluted for decorin (1:25), biglycan (1:50), fibromodulin (1:100), and lumican (1:100) were applied and incubated overnight at 4°C. This was followed by biotin-labelled rabbit IgG and peroxidase-labeled streptavidin application. 3- amino-9-ethylcarbazole was used for protein visualization after counterstaining with hematoxylin. The samples were observed under a light microscope. The negative controls were incubated with normal anti-rabbit IgG instead of the primary antibodies. We examined three different samples for each embryonic day to ensure that consistent results were obtained.

Organ culture and metabolic labeling with \[^35^S\] {#sec2-5}
---------------------------------------------------

An organ culture system was created according to a previous study.^[@ref16]^ Based on the results of *in situ* hybridization/ immunohistochemistry, we selected the lower first molar tooth germs of E16.0, E18.0, and P3.0 as representatives of the late cap stage, predentin formation stage, and enamel and dentin formation stage, respectively. A total of 36 explants of tooth germs were cultured on cell culture inserts (Millicell, Merck, Tokyo, Japan) containing BGJB medium (Gibco: Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin-streptomycin (Gibco) for 2 h in a humidified atmosphere of 5% CO~2~ in air at 37°C. Three tooth germs were placed on a cell culture insert. These explants were labeled with \[^35^S\]Na~2~SO~4~ (3.7 MBq/mL, American Radiolabeled Chemicals, St Louis, MO, USA) for another 12 h under the same culture conditions.

Extraction of proteoglycan and gel filtration {#sec2-6}
---------------------------------------------

After labeling, the explants were extracted with 4 M guanidine HCl, 50 mM sodium acetate, pH 6.0, containing 2% (w/v) Triton X-100 and 1% protease inhibitors (Sigma-Aldrich) at 4°C for 24 h. Each extract was subjected to a Sephadex G-50 column (Amersham Pharmacia Biotech, Tokyo, Japan) and eluted with 4 M guanidine HCl, 50 mM sodium acetate (pH 6.0) containing 0.5% (w/v) CHAPS to remove any unincorporated radioactive precursors. The collected void volume fractions were counted with a liquid scintillation counter and estimated as the total \[^35^S\]-labeled macromolecules per dish. To assess changes of synthesized \[^35^S\]- labeled macromolecules in amounts associated with tooth germ growth, data analyses were performed using one-way analysis of variance (ANOVA) for several group comparisons. Significance was determined using Tukey's comparison test. A P-value of \<0.05 was considered statistically significant.

The \[^35^S\]-labeled macromolecules from the Sephadex G-50 columns were then injected into prepacked Superose 6 columns (Amersham Pharmacia Bioteck) and eluted with 4 M guanidine HCl, 0.05 M sodium acetate (pH 6.0) containing 0.5% (w/v) Triton X-100 as previously described.^[@ref16]^ The fractions (0.4 mL each) were collected and counted.

Enzymatic treatment of PGs {#sec2-7}
--------------------------

\[^35^S\]-labeled macromolecules from the Sephadex G-50 columns were dialyzed against 0.1 M Tris-acetate buffer (pH 7.3) and digested with chondroitinase ABC (Seikagaku, Tokyo, Japan) (10 mU/μL) with protease inhibitors (10 mM EDTA, 10 mM Nethylmaleimide, 5 mM phenylmethylsulphonyl fluoride, 0.36 mM pepstatin A). One part of the chondroitinase ABC-digested samples was further digested with heparitinase (Seikagaku, Tokyo, Japan) (10 mU/μL) and/or keratanase (Seikagaku, Tokyo, Japan) (10 mU/μL) at 37°C for an additional 2 h. Finally, the enzyme-treated samples were subjected to the Superose 6 column.

Polyacrylamide gel electrophoresis (SDS-PAGE) {#sec2-8}
---------------------------------------------

Heparitinase-treated samples were applied to precast 5-20% gradient gels (Atto, Tokyo, Japan) and run at a constant current of 30 mA. Pre-stained molecular weight markers were used as standards (Life Technologies: Thermo Fisher Scientific). After electrophoresis, the gels were dried for 2 h at 60°C, then placed on an imaging plate (Fuji IP IN cassette) and analyzed by FCR PRIMA T2 (Fujifilm Medical, Tokyo, Japan).

Results {#sec1-3}
=======

*In situ* hybridization in mouse molar tooth germ {#sec2-9}
-------------------------------------------------

All terms related to tooth germ morphogenesis are according to Pieco and Avery.^[@ref15]^ At E13.5, the lower first molar tooth germ consisting of an epithelial tooth bud and condensed mesenchyme (future dental papilla) was at the bud stage, and mandibular bone started to surround it ([Figure 1 a](#fig001){ref-type="fig"},[f](#fig001){ref-type="fig"}) *Decorin, biglycan*, and *fibromodulin* mRNAs were expressed in various tissues in the mandible ([Figure 1 b-d](#fig001){ref-type="fig"}). Focusing on tooth germ, *decorin* mRNA was expressed in the surrounding mesenchyme, but not within the tooth germ ([Figure 1g](#fig001){ref-type="fig"}), *Biglycan* mRNA was well expressed in the condensing mesenchyme of the tooth germ, but was not expressed within the epithelial tooth bud ([Figure 1h](#fig001){ref-type="fig"}). *Fibromodulin* mRNA did not show significant expression within the tooth germ ([Figure 1i](#fig001){ref-type="fig"}). *Lumican* mRNA did not show significant expression in any regions at this stage ([Figure 1e](#fig001){ref-type="fig"}). This was similar for *lumican* mRNA at all stages examined in the present study (*data not shown*). Since each mRNA showed similar expression patterns at E15.0 and E16.0, we describe results at E16.0 as representative. At E16.0, the masseter muscle was attached to the developing mandibular bone, which surrounded the tooth germ in the late cap stage ([Figure 2 a](#fig002){ref-type="fig"},[e](#fig002){ref-type="fig"}). *Decorin* mRNA was expressed in the mesenchyme around the tooth germ, although not within it ([Figure 2 b](#fig002){ref-type="fig"},[f](#fig002){ref-type="fig"}). *Biglycan* mRNA showed expression patterns similar to those of *decorin*; however, it was additionally expressed in the dental papillae ([Figure 2 c](#fig002){ref-type="fig"},[g](#fig002){ref-type="fig"}). *Fibromodulin* mRNA did not show significant expression within the tooth germ ([Figure 2h](#fig002){ref-type="fig"}). Note that each mRNA was expressed in the epimysium of the masseter muscle ([Figure 2 b-d](#fig002){ref-type="fig"}). At E18.5, the tooth germ was in the apposition stage (late bell stage), and predentin formation with differentiating odontoblasts was evident at the cusp tip ([Figure 3a](#fig003){ref-type="fig"}). *Decorin* mRNA was well expressed in differentiating odontoblasts, as well as in the dental papilla beneath the odontoblastic layer at the cusp region ([Figure 3b](#fig003){ref-type="fig"}). However, *biglycan* mRNA was expressed at a lesser intensity than *decorin* and was only localized to odontoblasts at the cusp tips ([Figure 3c](#fig003){ref-type="fig"}). *Fibromodulin* mRNA was expressed in the epimysium of the masseter muscle, although not within the tooth germ ([Figure 3d](#fig003){ref-type="fig"}). Note that the epimysium also showed *decorin* and *biglycan* mRNA ([Figure 3 b](#fig003){ref-type="fig"},[c](#fig003){ref-type="fig"}). At P1.0, dentin formation was clearly evident ([Figure 3e](#fig003){ref-type="fig"}). *Decorin* mRNA expression was reduced in mature odontoblasts facing dentin; however, it remained well expressed in the newly differentiating odontoblasts towards the cervical part of the tooth germ ([Figure 3f](#fig003){ref-type="fig"}). In contrast, *biglycan* expression was enhanced in the mature odontoblasts, but remained weakly expressed in the newly differentiating odontoblasts ([Figure 3g](#fig003){ref-type="fig"}). *Decorin* and *biglycan* mRNA were also detected in the dental papillae beneath the odontoblastic layers; however, the expression of the former was slightly stronger than the latter ([Figure 3 f](#fig003){ref-type="fig"},[g](#fig003){ref-type="fig"}). The epimysium was found to still express every mRNA examined at this stage ([Figure 3 f-h](#fig003){ref-type="fig"}). At P3.0, dentin, as well as enamel formation, were evident ([Figure 4a](#fig004){ref-type="fig"}). Strong *decorin* mRNA expression was localized in the newly differentiating odontoblasts at the cervical region ([Figure 4b](#fig004){ref-type="fig"}). Meanwhile, *biglycan* mRNA was expressed strongly throughout the odontoblastic layer ([Figure 4c](#fig004){ref-type="fig"}). The dental papillae showed similar expression patterns for *decorin* and *biglycan* to those at P1.0 ([Figure 4 b](#fig004){ref-type="fig"},[c](#fig004){ref-type="fig"}). *Fibromodulin* mRNA was expressed in the epimysium, but it was not expressed within the tooth germ ([Figure 4d](#fig004){ref-type="fig"}). Notably, not every mRNA was expressed at all stages in the ameloblasts ([Figure 4 b-d](#fig004){ref-type="fig"}).

At P7.0, crown formation was found to have advanced, with Hertwig's epithelial root sheath having started to form ([Figure 4e](#fig004){ref-type="fig"}). *Decorin* mRNA expression was completely reduced, although it remained at the cervical tip, that is, where the new odontoblasts were being differentiated ([Figure 4f](#fig004){ref-type="fig"}). *Biglycan* mRNA expression was also reduced, although it remained weakly expressed throughout the odontoblastic layer ([Figure 4g](#fig004){ref-type="fig"}). The dental papilla at the coronal region weakly expressed *decorin* and *biglycan* mRNAs ([Figure 4 f](#fig004){ref-type="fig"},[g](#fig004){ref-type="fig"}).

![Frontally cut mouse head (a-e) and enlargement of lower molar tooth germ (TG) (f-i) at E13.5. TB staining (a,f ) and *in situ* hybridization for *decorin* mRNA (b,g), *biglycan* mRNA (c,h), *fibromodulin* mRNA (d,i), and *lumican* mRNA (e). a,f ) Tooth germ at the bud stage, developing tongue muscle (T), and mandibular bone (MB) with Meckel's cartilage (MC) were seen. b,g) *Decorin* mRNA was expressed in tongue muscles, surrounding mesenchyme of the submandibular gland, developing mandibular bone (asterisks), and mesenchyme around tooth germ (arrowheads). c,h) *Biglycan* mRNAs was expressed in the lingual septum, perichondrium of Meckel's cartilage, developing mandibular bone (asterisks), and condensing mesenchyme of the tooth germ (arrowheads). d,i) *Fibromodulin* mRNA was weakly expressed in the perichondrium of Meckel's cartilage and the mandibular bone (asterisks), but not in the tooth germ. e) *Lumican* mRNA did not show significant expression. Scale bars: a-e) 200 mm; f-i) 80 mm.](ejh-64-1-3092-g001){#fig001}

![Frontally cut mouse head (a-d) and magnification of lower molar tooth germ (TG) (e-h) at E16.0. TB staining (a,e) and *in situ* hybridization for *decorin* (b,f ), *biglycan* (c,g), and *fibromodulin* mRNA (d,h). a,e) Masseter muscle (MM) was attached to developing mandibular bone (MB); developing tooth germ was in the late cap stage. a-h) *Decorin* mRNA was expressed in the periosteum of the mandibular bone (asterisk in b), and the mesenchyme around the tooth germ (arrowheads in b and f ). *Biglycan* mRNA was expressed in the periosteum of the mandibular bone (asterisk in c), and additionally in dental papillae (arrowheads in c and g). *Fibromodulin* mRNA was not expressed in tooth germ. Note that three mRNAs were expressed in the epimysium of the masseter muscle (arrows in b-d). Scale bars: 50 mm.](ejh-64-1-3092-g002){#fig002}

*In situ* hybridization in mouse incisor tooth germ and in lower limb tendons and epimysium {#sec2-10}
-------------------------------------------------------------------------------------------

The incisor tooth germ at P7.0 cut at the sagittal plane showed every stage of differentiating odontoblast ([Figure 5a](#fig005){ref-type="fig"}). *Decorin* mRNA expression was detected in newly differentiating odontoblasts, although it was gradually reduced towards the coronal region ([Figure 5b](#fig005){ref-type="fig"}). *Biglycan* mRNA expression started to be detected in odontoblasts at a similar position to that showing *decorin* mRNA expression; however, the odontoblasts maintained *biglycan* mRNA expression more towards the tip region compared to *decorin* ([Figure 5c](#fig005){ref-type="fig"}). The tendon of the quadriceps femoris muscle was continuous to the epimysium of the tibialis anterior muscle at P1.0 ([Figure 5d](#fig005){ref-type="fig"}). The tendon, the epimysium, and the perimysium all expressed *decorin, biglycan*, and *fibromodulin* mRNA, although the expression of *decorin* mRNA was weak in the epimysium while strong in the perimysium ([Figure 5 e-g](#fig005){ref-type="fig"}).

![Frontally cut mouse lower molar tooth germs at E18.5 (ad) and at P1.0 (e-h). TB staining (a,e) and *in situ* hybridization for *decorin* (b,f ), *biglycan* (c,g) and *fibromodulin* mRNA (d, h). a e) Odontoblasts (OB) with formation of predentin (PD) and/or dentin (D) were evident at cusp tips. b-d) *Decorin* mRNA was well expressed in differentiating odontoblasts at cup tips (arrowhead in b) and dental papillae beneath them (asterisks in b); *biglycan* mRNA was expressed at low intensity in differentiating odontoblasts (arrowheads in c); *fibromodulin* mRNA was not expressed within the tooth germ. f-h) *Decorin* mRNA expression was reduced in mature odontoblasts (arrowheads in f ), but extended to newly differentiating odontoblasts in the cervical region (arrows in f ) and also in the dental pulp beneath odontoblasts (asterisks in f ); *biglycan* mRNA expression was enhanced in mature odontoblasts (arrowheads in g) and underlying dental pulp (asterisks in g), but still weak in newly differentiating odontoblasts (arrows in g); *fibromodulin* mRNA was not expressed within the tooth germ. All mRNAs were expressed in the epimysium of masseter muscles (large arrows in b-d, f-h). Scale bars: 100 mm.](ejh-64-1-3092-g003){#fig003}

![Frontally cut mouse lower molar tooth germs at P3.0 (ad) and P7.0 (e-g). TB staining (a,e) and *in situ* hybridization for *decorin* (b,f ), *biglycan* (c,g), and *fibromodulin* mRNA (d). a,e) Dentin (D) and enamel (E) formation were evident, and Hertwig\'s epithelial root sheath (HERS) had started to form. bd) *Decorin* mRNA expression was localized in the newly differentiating odontoblasts at the cervical region (arrowheads in b) and underlying pulp (asterisks in b); *biglyca*n mRNA was expressed strongly throughout the odontoblast layer (arrowheads in c) and underlying pulp (asterisks in c); *fibromodulin* mRNA was not expressed within the tooth germ (d). f,g) *Decorin* mRNA expression only remained in odontoblasts at the cervical tip (arrowheads in f ) and weakly in the coronal pulp (asterisk in f ); *biglycan* mRNA expression was also reduced, but remained weak throughout the odontoblast layer (arrowheads in g) and in the coronal pulp (asterisk in g). Epimysium of masseter muscles expressed all three mRNAs (arrows in b-d). OB, odontoblasts; PD, predentin. Scale bars: 100 mm.](ejh-64-1-3092-g004){#fig004}

Immunohistochemistry in mouse molar tooth germ {#sec2-11}
----------------------------------------------

At E16.0, although biglycan immunoreactivity was detected in the dental papilla, other immunoreactivities were not detected within the tooth germ ([Figure 6 a-d](#fig006){ref-type="fig"}). Despite this, decorin immunoreactivity was detected in the lamina propria of the oral mucosa around the tooth germ ([Figure 6a](#fig006){ref-type="fig"}). These findings correlated with mRNA expression patterns; however, in contrast to the mRNA findings, lumican immunoreactivity was detected in the osteoid of the mandibular bone ([Figure 6d](#fig006){ref-type="fig"}). At E18.5, immunoreactivity for four SLRPs was detected in the predentin and osteoid ([Figure 6 e-h](#fig006){ref-type="fig"}). These results were in accordance with mRNA expression for *decorin* and *biglycan* in odontoblasts, indicating that these molecules were mainly synthesized by odontoblasts, but not in accordance with the mRNA expression for *fibromodulin* and *lumican*.

Biglycan immunoreactivity was also detected in the central region of the dental pulp; however, it was weakly expressed in the peripheral region beneath the odontoblastic layer where its mRNA expression was clearly detected ([Figure 6f](#fig006){ref-type="fig"}). From P1.0 (*data not shown*) to P3.0, immunoreactivities showed similar expression patterns to those at E18.5. Notably, immunoreactivity was detected neither in the dentin nor in the enamel ([Figure 6 i-l](#fig006){ref-type="fig"}).

Analysis of SLRPs synthesized by tooth germ explants {#sec2-12}
----------------------------------------------------

In the explant cultures, the amount of \[^35^S\]-labeled macromolecules released into the explants at E18.0 was significantly larger than that at E16.0, and that at P3.0 was further significantly larger than that at E18.0, indicating that the amount of synthesized macromolecules increased in association with tooth germ growth ([Figure 7a](#fig007){ref-type="fig"}). A \[^35^S\]-labeled tissue sample from each day was analyzed by Superose 6 gel chromatography ([Figure 7b](#fig007){ref-type="fig"}). Intact samples from E16.0 and E18.0 showed similar elusion profiles. In both samples, a major peak eluted at V0 (peak 1) and a broad peak eluted at K^d^ = 0.23 (peak 2) were observed. The ratios of \[^35^S\] radioactivity in peaks 1 and 2 to total radioactivity were \~69% and \~29% at E16.0 and \~51% and \~39% at E18.0, respectively. Peaks 1 and 2 at E16.0 were somewhat susceptible to chondroitinase ABC, while only \~5% of \[^35^S\] radioactivity remained in the regions of peaks 1 and 2 and was not susceptible to digestion by heparitinase or keratanase, indicating small amounts of synthesized HS-PGs and KS-PGs. At E18.0, \~27% of \[^35^S\] radioactivity remained in peak 1 and 2 regions after chondroitinase ABC digestion. About 10% of \[^35^S\] radioactivity in the remaining peaks was susceptible to heparitinase; however, it was not susceptible to subsequent digestion by keratanase, indicating that a significant amount of HS-PGs was synthesized, while KS-PGs was synthesized at low levels. In addition, a third peak was disclosed at K~d~ = 0.68 after chondroitinase ABC digestion and was not susceptible to either heparitinase or keratanase. The remaining peaks at the 1 and 2 regions and peak 3 may represent sulfated proteins or sulfated glycoproteins. However, the necessary analyses for their elucidation did not fall within the scope of this study. At P3.0, peak 1 became small, while other peaks were recognized at K~d~ = 0.48 (peak 4) and K~d~ = 0.70 (peak 5). Since these peaks were not susceptible to enzymatic treatments, they may represent sulfated proteins or glycoproteins. Peaks 1 and 2 were susceptible to chondroitinase ABC. The remaining peak (\~11%) was further susceptible to heparitinase, but was not susceptible to keratanase, indicating that significant amounts of HS-PGs were also synthesized, while KS-PGs were synthesized at low levels.

![Sagittally cut mouse incisor tooth germ at P7.0 (a-c) and sagittally cut mouse lower limb at P1.0 (d-g). TB staining (a,d) and *in situ* hybridization for *decorin* (b,e), *biglycan* (c,f ), and *fibromodulin* mRNA (g). a) All differential stages of odontoblasts can be identified (arrowheads in a). b, c) *Decorin* mRNA was expressed in newly differentiating odontoblasts and reduced towards the coronal region (arrowheads in c); *biglycan* mRNA was also expressed in odontoblasts and maintained its reactivity more towards the tip region (arrowheads in c). d) Tendons of the quadriceps femoris muscle (QFt) were continuous to the epimysium (em) of the tibialis anterior muscle (TA). e-g) Three mRNAs were expressed in the tendons (arrows), the continuous epimysium (arrowheads), and in the perimysium (asterisks), although *decorin* was weakly expressed in the epimysium (arrowhead in e). Scale bars: 200 mm.](ejh-64-1-3092-g005){#fig005}

![Immunohistochemistry in frontally cut mouse molar tooth germs at E16.0 (a-d), E18.5 (e-h), and P3.0 (i-l) for decorin (a,e,i), biglycan (b,f,j), fibromodulin (c,g,k), and lumican (d,h,l) proteins. a-d) Decorin immunoreactivity was detected in the lamina propria of oral epithelium (arrowhead in a); biglycan immunoreactivity was detected in the dental papillae (asterisk in b). Lumican immunoreactivity was detected in the osteoid (arrowhead in d). e-l) Immunoreactivity for all SLRPs was detected in the predentin (arrows) and osteoid (arrowheads); biglycan immunoreactivity was additionally detected in the central region of the dental pulp (asterisks in f and j), but not in the peripheral region (black circles in f and j). Scale bars: 100 mm.](ejh-64-1-3092-g006){#fig006}

SDS-PAGE analyses {#sec2-13}
-----------------

Since the specimens investigated above were found to potentially contain significant amounts of HS-PGs, they were subjected to SDS-PAGE after heparitinase digestion. One band outside the gel (band 1) and two broad bands \[\~250 kDa (band 2) and \~100 kDa (band 3)\] were observed in all three stages ([Figure 7c](#fig007){ref-type="fig"}). Compared to E16.0 and E18.0, band 2 of P3.0 was significantly thicker than band 3. According to previous studies^[@ref36],[@ref37]^ bands 1, 2, and 3 correspond to versican-type large PG, biglycan-type small PG, and decorin-type small PG, respectively. Hence, the tooth germ at P3.0 synthesized higher amounts of biglycan-type PG than decorin-type PG.

Discussion {#sec1-4}
==========

Expression of *decorin* and *biglycan* mRNAs in odontoblasts with the formation of predentin/dentin {#sec2-14}
---------------------------------------------------------------------------------------------------

In the present study, *decorin* and *biglycan* mRNAs were more highly expressed than *fibromodulin* and *lumican* mRNAs in developing mouse molar tooth germ. In addition, the explant cultures indicated that KS-PGs were synthesized at low levels by tooth germs from E16.0 to P3.0, suggesting that the involvement of KS-PGs (*e.g*. fibromodulin and lumican) in tooth formation was less than that of CS-PGs (*e.g*. versican, decorin, and biglycan). Although a previous study reported that *fibromodulin* mRNA is expressed in the outer enamel epithelium and *lumican* mRNA in the dental papillae of E14.5 mice incisors,^[@ref28]^ our results suggest that tooth germs express *fibromodulin* and *lumican* mRNAs in small amounts, as they were observed at a low intensity during our procedure. Thus, the relationship of decorin and biglycan to tooth formation was the main focus of the present study.

![a) \[^35^S\]-labeled macromolecules released into explants at E16.0, 18.0, and P3.0. From E16.0 to E18.0, the amount of macromolecules was significantly increased, and was further increased at P3.0 compared with E18.0; data are presented as means ± SD (n = 4); \*P\<0.01, significantly different between indicated groups; \*\*P\<0.05, significantly different between indicated groups. b) Superose 6 elution profiles of explants from E16.0, 18.0, and P3.0 with or without enzymatic treatments; peaks 1 and 2 in E16.0 samples were slightly susceptible to chondroitinase ABC, and remaining peaks at 1 and 2 regions were not susceptible to digestion of heparitinase and keratanase. In E18.0 samples, remaining peaks at 1 and 2 regions after chondroitinase ABC digestion, were susceptible to heparitinase (\~10%), but were not susceptible to subsequent digestion by keratanase. Peak 3 was not susceptible to either heparitinase or keratanase; in the P3.0 sample, peak 1 became small and peaks 1 and 2 were largely susceptible to chondroitinase ABC, and remaining peaks were further susceptible to heparitinase, but not susceptible to keratanase; peak 4 and 5 were also recognized, but were not susceptible to any enzymatic treatment. c) SDS-PAGE analysis; a band at the top of the gel (band 1), and two broad bands of \~250 kDa (band 2) and \~100kDa (band 3), were recognized for all three ages. Compared to E16.0 and E18.0, band 2 of P3.0 was significantly thicker than band 3.](ejh-64-1-3092-g007){#fig007}

As *biglycan* mRNA was expressed at every developmental stage of the mouse molar tooth germ, we considered it to be the most abundant molecule among the four SLRPs examined. Notably, *decorin* and *biglycan* mRNAs were found to be differentially expressed in odontoblasts. At the predentin formation stage (E18.5), *decorin* mRNA was well expressed in the differentiating odontoblasts at the cusp tip, while the expression of *biglycan* mRNA was low. With the formation of dentin (P1.0 to 3.0), *decorin* mRNA expression was decreased in that area, being more localized to the newly differentiating odontoblasts towards the cervical part of the tooth germ. Simultaneously, *biglycan* mRNA expression became more intense, being expressed throughout the new and mature odontoblasts. This change in the pattern of expression strongly supports the idea that they play different roles in tooth formation by regulating odontoblast differentiation, as we hypothesized.

The expression of *decorin* and *biglycan* mRNAs in odontoblasts has been previously reported.^[@ref29],[@ref30]^ Hikake *et al.*^[@ref30]^ reported changes in the expression of *decorin* and *biglycan* mRNAs in the odontoblasts of mouse molar tooth germs from E18.5 to P4.5. Although their findings partially correlate with the results presented here, they mainly focused on the co-expression of *decorin/biglycan* mRNA with *OASIS* mRNAs, without referring to the distinct expression patterns between *decorin* and *biglycan*. Matsuura *et al.*^[@ref29]^ found that *decorin* and *biglycan* show distinct expression patterns, proposing that these molecules have different roles in odontoblast differentiation. Although we agree with their hypothesis, the expression patterns described in their study were slightly different from our own findings. Matsuura *et al.*^[@ref29]^ demonstrated that *biglycan* mRNA is expressed in presecretory odontoblasts and is weak in secretory odontoblasts, whereas *decorin* mRNA is highly expressed in secretory odontoblasts. They used an upper first molar at E19.0 (newborn) as the dentin-secretory stage, with their results being mostly consistent with ours at E18.5. Furthermore, they used a lower incisor at E19.0 as the later stage (dentin/enamel secretory stage), obtaining the above results. We investigated changes in the temporal expression patterns in identical tooth germs (lower first molars), resulting in the expression patterns described above. The incisor results correlated with the fact that *biglycan* mRNA is expressed in mature odontoblasts at later stages.

The differentiation of dental papillae cells at the interface with the enamel organs results in the appearance of odontoblasts, which subsequently secrete predentin matrix.^[@ref15]^ To assess the function of decorin and biglycan in tooth formation, Goldberg *et al.*^[@ref25]^ analyzed both *decorin*-deficient and *biglycan*-deficient mice. They performed immunohistochemistry for decorin and biglycan in molar tooth germs of wild-type mice at P1.0; they described strong immunoreactivities for both molecules in predentin and weak biglycan immunoreactivity in odontoblasts and enamel organs including ameloblasts, stratum intermedium, and stellate reticulum. Except for biglycan immunoreactivity in dental papillae (discussed later), our results did not show immunoreactivity in tissues other than predentin. This slight discrepancy may be due to the different antibodies used or our pre-treatment of sections with hyaluronidase. In any case, our immunohistochemistry results from E18.5 to P3.0 agreed with those of Goldberg *et al*.^[@ref25]^ in that predentin showed strong immunoreactivity for both molecules, and our *in situ* hybridization results confirmed that they are mainly secreted by odontoblasts.

Based on analyses of gene-knockout mice, Goldberg *et al*.^[@ref25]^ suggested the involvement of decorin and biglycan in enamel formation; the former accelerates it, but the latter inhibits it. Our results indicate that the abnormality of enamel formation in their gene-knockout mice seems to have been due to an impairment of dentin/predentin formation, since we recognized no significant mRNA expression for either molecule in ameloblasts. In contrast to our results, Matsuura *et al.*^[@ref29]^ reported *biglycan* mRNA expression in ameloblasts. While Matsuura *et al.*^[@ref29]^ used digoxigenin-labeled probes for cryo-sections, we used RI-labeled probes for paraffin sections. As such, this discrepancy may be the result of the use of different probes and/or labeling methods. Since significant immunoreactivity was not detected in the enamel matrix or ameloblasts, we believe that ameloblasts synthesize and secrete only small amounts of SLRPs, including biglycan.

Goldberg *et al*.^[@ref25]^ also demonstrated that biglycan, but not decorin, controls collagen fibrogenesis in predentin, and that decorin, and to a lesser extent biglycan, promote dentin mineralization. The functions of decorin and biglycan in these phenomena are somewhat controversial according to previous studies. Some studies suggest that decorin regulates collagen fibrillogenesis by binding to many types of collagen, including types I, II, and III.^[@ref38]^ In the absence of *decorin*, irregular collagen contours and diameters arise in various types of tissues, including the skin and tendons, as well as in the periodontal ligaments.^[@ref9],[@ref26]^ An *in vivo* study indicated that decorin is a negative regulator of mineralization,^[@ref39]^ but an *in vitro* study indicated that decorin had no effect on mineral accumulation.^[@ref40]^ *Decorin*-deficient mice do not show osteoporosis-like phenotypes.^[@ref25]^ Biglycan however has been suggested to be an accelerator of matrix mineralization,^[@ref40]^ and *biglycan*-deficient mice show osteoporosis-like phenotypes^[@ref10]^ and also have hypomineralized dentin.^[@ref25],[@ref41]^

Immunohistochemistry analysis showed both decorin and biglycan immunoreactivity in the predentin, although not in mineralized dentin. Similar results have been reported by previous studies in mouse molars,^[@ref25],[@ref42]^ mouse incisors,^[@ref23]^ and rat molars.^[@ref21]^ These results also support the hypothesis that both molecules are involved in dentin formation in terms of predentin formation and/or its mineralization.

These complicated results may indicate discrepancies between *in vitro* and *in vivo* experiments or between dentin and bone. In any case, our histological study cannot confirm whether the proposed hypotheses are correct or not, but at least it indicates that predentin/dentin formation may progress *via* two steps: a *decorin*prevailing initial step and a *biglycan*-prevailing subsequent step. It is well known that the two mechanisms achieve mineralization; the first involves matrix vesicles, and the second involves heterogenous nucleation along with collagen fibrils, and this is used in dentin mineralization.^[@ref43]^ The present results can classify the second step into further two steps. Further studies, however, are required to clarify this hypothesis while taking the relationship between decorin/biglycan and small integrin-binding ligand N-linked glycoproteins (SIBLINGs) into consideration, since SIBLINGs are known to be involved in dentin mineralization.^[@ref25],\ [@ref41]^

Furthermore, Goldberg *et al.*^[@ref25]^ found that dentin hypomineralization observed in newborn mice with decorin and biglycan gene-knockout had undergone self-repair in adult mice, suggesting that decorin and biglycan may be involved in the initial process of mineralization, but that it is subsequently taken over by other molecules. In the present study, mRNA expression for both molecules was reduced at P7.0 despite dentin formation being a continuous process, which further supports this hypothesis.

Expression of *decorin* and *biglycan* mRNA/proteins in dental papillae/dental pulp {#sec2-15}
-----------------------------------------------------------------------------------

The present study showed that both *decorin* and *biglycan* mRNA were expressed in the dental papillae beneath the odontoblastic layers at the cusp regions, in line with their strong expression in odontoblasts. However, immunohistochemistry analyses indicated that only biglycan immunoreactivity was consistently present in the dental papillae/pulp. Goldberg *et al.*^[@ref25]^ did not report biglycan immunoreactivity in the dental papillae of wildtype mice at P1.0. This may be due to pretreatment of sections with hyaluronidase in the present study, since GAG chains of proteoglycans often block immunoreactivity of core proteins.^[@ref44]^ At E18.5, biglycan was strongly expressed in the central region, but was weak in the peripheral region beneath the odontoblastic layer, indicating that the dental pulp cells beneath the odontoblastic layer may secrete biglycan protein into the central region.

The distribution patterns of biglycan immunoreactivity in the dental pulp were similar to those of versican^[@ref16]^ or perlecan.^[@ref17]^ Filling spaces for the development of organs appears to be an important function of large PGs, such as versican.^[@ref45]^ Thus, biglycan may be related to the development of dental papillae/pulp together with other PGs. The region immediately below the odontoblast layer is known as the cell-rich zone.^[@ref15]^ Cells in this zone are capable of differentiating into odontoblasts when the initial cells are damaged, and may be involved in the transport and reabsorption of fluid and ions from the pulp to odontoblastic layer.^[@ref46],[@ref47]^ Thus, decorin and/or biglycan may also exert such functions. Future experimental studies that induce damage to the dental pulp and accelerate tissue repair may clarify this hypothesis.

Protein synthesis analyzed by organ culture with metabolic labeling of \[^35^S\] {#sec2-16}
--------------------------------------------------------------------------------

In the present study, compared to CS-PGs, KS-PGs were found to be synthesized at low levels by tooth germs from E16.0 to P3.0. These results support the *in situ* hybridization results, wherein the expression of *fibromodulin* and *lumican* mRNA were not detected at any stage of the tooth germs examined. Significant amounts of HS-PGs, however, were synthesized by tooth germs at E18.0 and P3.0. Ida-Yonemochi *et al.*^[@ref17]^ investigated the expression and synthesis of perlecan, a representative large HS-PG, and demonstrated its involvement in tooth formation. Furthermore, the expression of the syndecan family, which are principal cell-surface HS-PGs, has also been reported in the developing tooth germ,^[@ref48],[@ref18]^ indicating that the HS-PGs synthesized in the present study may correspond to these types of PGs. In addition, sulfated proteins were synthesized by the tooth germ at P3.0. Previous studies have suggested that bone/tooth-related proteins, such as bone sialoprotein (BSP), often undergo sulfation.^[@ref49]^ Thus, the sulfated proteins in the present study may correspond to these proteins. Further structural analyses will be required to confirm the characteristics of these HSPGs or sulfated proteins. With regard to CS-PGs, we confirmed versican-type large PGs and biglycan- and decorin-type small PGs by SDS-PAGE. Among the two molecules, the biglycan-type PG was primarily synthesized by the tooth germ at P3.0, supporting our *in situ* hybridization and immunohistochemistry results at P3.0 showing that biglycan was predominant.

The incorporation of decorin/biglycan with growth factors has been previously reported in various cell types.^[@ref2],[@ref50]^ In particular, decorin has been found to inhibit cell proliferation by activating EGF receptors^[@ref51],[@ref52]^ such that the initial expression of *decorin* mRNA may play a role in maintaining the non-proliferative single layer of odontoblast cells. Further studies investigating the expression of growth factors will be required to test this hypothesis.

Expression of fibromodulin and lumican {#sec2-17}
--------------------------------------

Although *fibromodulin* and *lumican* mRNA were not detected, and the synthesis of KS-PGs was detected at low levels in the tooth germs of mice at P3.0, immunoreactivity to both molecules was observed in the predentin. This may be the result of a small amount of proteins being synthesized by the odontoblasts and accumulated in the predentin.

Previous immunohistochemical studies have demonstrated the presence of fibromodulin^[@ref23],[@ref53]^ and lumican^[@ref13]^ in the predentin. Goldberg *et al.*^[@ref53]^ demonstrated altered dentin mineralization in *fibromodulin*-deficient mice at P1.0, and hence insisted that fibromodulin regulates dentin mineralization and the early stages of enamel formation. In the present study, although the immunoreactivity of these two molecules was also detected in the osteoid of the mandibular bone, it was not detected in mineralized dentin or bone. This indicates that these molecules may be related to mineralization together with decorin/biglycan, supporting the theory presented by Goldberg *et al.*^[@ref53]^

Although the expression of *fibromodulin* mRNA was not detected in the tooth germ, it was highly expressed in the epimysium of the masseter muscle at all stages examined and was co-expressed with *decorin* and *biglycan* mRNA. Similar expression patterns were also observed in the tendons of the quadriceps femoris muscle and in the epimysium of the tibialis anterior muscle, although the expression intensity varied between the different molecules. These results correlated with those reported by previous studies in which *decorin*, *biglycan*, and *fibromodulin* expression have been reported in muscles and tendons.^[@ref54],[@ref55]^ The absence of their expression has been associated with altered collagen diameters and irregular collagen fibril outlines.^[@ref56],[@ref57]^ *Biglycan* and *fibromodulin* double-knockout mice show an impaired gait, ectopic tendon ossification, and osteoarthritis phenotypes.^[@ref58]^ These findings suggest that the co-expression of these three mRNAs seems to be a general structural feature in tendons and/or the epimysium, and they are involved in regulating fibrillogenesis and the inhibition of excessive mineralization. In this study, *decorin*, *biglycan*, and *fibromodulin* were not highly expressed in other epimysia of muscles in the craniofacial region (*data not shown*), indicating that the expression of these three SLRPs has muscle-specific variations.

To conclude, the present study suggests that SLRPs show different expression patterns in each stage of tooth development, suggesting that SLRPs may have their own tissue-specific roles. In particular, biglycan was found to be the most abundant molecule among the four SLRPs examined.
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